Abstract
The discovery of Helicobacter pylori (H. pylori), the curved or spiral shaped bacteria, as the main etiologic organism of chronic gastritis, peptic ulcer disease, and gastric cancer was one the most significant discoveries in gastroenterology of the twentieth century. Helicobacter infections promote infiltration of the gastric mucosa by neutrophils, macrophages, and T and B lymphocytes, and leaves the host prone to complications resulting from chronic inflammation. If left untreated, persistent gastrointestinal infections and chronic gastritis may evolve into more severe diseases, such as peptic ulcer or atrophic gastritis. In addition, infection with H. pylori increases the risk of developing gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Helicobacter pylori infections are of great concern worldwide due to increasing antimicrobial resistance and high re-infection rates. In the 1990’s scientific evaluation of natural products and ethnomedicines for the treatment of H. pylori infections began in earnest, and many natural products have been investigated over the past 20 years with promising in vitro results. This review highlights these achievements and the classes of naturally occurring compounds with activity against H. pylori. It also points out the critical need of new treatments for H. pylori infections due to increasing global resistance.
Keywords: Helicobacter pylori, ethnomedicine, gastritis, natural products, peptic ulcer disease.
Current Bioactive Compounds
Title:Susceptibility of Helicobacter pylori to Natural Products: Can Past Research Direct Future Drug Development?
Volume: 8 Issue: 3
Author(s): Temitope O. Lawal, Kapil K. Soni, Brian J. Doyle, Bolanle A. Adeniyi and Gail B. Mahady
Affiliation:
Keywords: Helicobacter pylori, ethnomedicine, gastritis, natural products, peptic ulcer disease.
Abstract: The discovery of Helicobacter pylori (H. pylori), the curved or spiral shaped bacteria, as the main etiologic organism of chronic gastritis, peptic ulcer disease, and gastric cancer was one the most significant discoveries in gastroenterology of the twentieth century. Helicobacter infections promote infiltration of the gastric mucosa by neutrophils, macrophages, and T and B lymphocytes, and leaves the host prone to complications resulting from chronic inflammation. If left untreated, persistent gastrointestinal infections and chronic gastritis may evolve into more severe diseases, such as peptic ulcer or atrophic gastritis. In addition, infection with H. pylori increases the risk of developing gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. Helicobacter pylori infections are of great concern worldwide due to increasing antimicrobial resistance and high re-infection rates. In the 1990’s scientific evaluation of natural products and ethnomedicines for the treatment of H. pylori infections began in earnest, and many natural products have been investigated over the past 20 years with promising in vitro results. This review highlights these achievements and the classes of naturally occurring compounds with activity against H. pylori. It also points out the critical need of new treatments for H. pylori infections due to increasing global resistance.
Export Options
About this article
Cite this article as:
Lawal O. Temitope, Soni K. Kapil, Doyle J. Brian, Adeniyi A. Bolanle and Mahady B. Gail, Susceptibility of Helicobacter pylori to Natural Products: Can Past Research Direct Future Drug Development?, Current Bioactive Compounds 2012; 8 (3) . https://dx.doi.org/10.2174/157340712802762447
DOI https://dx.doi.org/10.2174/157340712802762447 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Challenges and Promises of Developing Thrombin Receptor Antagonists
Recent Patents on Cardiovascular Drug Discovery Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction?
Cardiovascular & Hematological Disorders-Drug Targets Medicinal Research Progress of Natural Coumarin and its Derivatives
The Natural Products Journal Medicinal Chemistry of Drugs Used in Diabetic Cardiomyopathy
Current Medicinal Chemistry Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
Current Cardiology Reviews Omega-3 and Renal Function in Older Adults
Current Pharmaceutical Design Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways
Current Molecular Medicine Biomarkers of Aspirin Resistance
Recent Patents on Biomarkers Risk Factors and Potential Preventive Measures for Vascular Disease Progression in Hemodialysis Patients
Vascular Disease Prevention (Discontinued) Cystatin C, Adipokines and Cardiovascular Risk in HIV Infected Patients
Current HIV Research Fenofibrate and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management
Current Vascular Pharmacology Unmet Needs in Schizophrenia
CNS & Neurological Disorders - Drug Targets Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Renal Function, Albumin-Creatinine Ratio and Pulse Wave Velocity Predict Silent Coronary Artery Disease and Renal Outcome in Type 2 Diabetic and Prediabetic Subjects
Current Hypertension Reviews Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Optimal Dosing Design for Antibiotic Therapy in the Elderly: A Pharmacokinetic and Pharmacodynamic Perspective
Recent Patents on Anti-Infective Drug Discovery Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Fabrication and Physicochemical and Medicinal Characterization of Nano Traditional Chinese Medicine
Recent Patents on Engineering Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry